Gallant is a pioneering company in the field of stem cell storage and regenerative therapy, specifically designed for dogs. The company offers a unique service that allows pet owners to bank their dog's stem cells during routine procedures like spaying or neutering. These stem cells can later be used for regenerative treatments to address various health issues such as arthritis, joint pain, and limited mobility, which are common in aging dogs. Gallant primarily serves pet owners who are proactive about their pets' long-term health and well-being. Operating in the pet healthcare market, Gallant employs a direct-to-consumer business model, making money through the sale of stem cell banking plans and subsequent regenerative treatments. The company leverages scientific advancements to provide a service that not only enhances the quality of life for pets but also offers peace of mind for their owners. By partnering with veterinarians, Gallant ensures a seamless process for stem cell collection and storage, making it convenient for pet owners to invest in their pets' future health.

Keywords: stem cell storage, regenerative therapy, pet healthcare, dog wellness, arthritis treatment, joint pain relief, veterinary partnership, spay neuter, stem cell banking, pet longevity.